Cordlife Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLIFF research report →
Price Chart
About the company
As an investment holding company, Cordlife Group Limited offers cord blood banking solutions across various countries including Singapore, Hong Kong, India, Malaysia, and the Philippines, extending its reach globally. Its operations are structured into two distinct segments: Banking and Diagnostics. The Banking segment is dedicated to the processing and secure storage of stem cells derived from cord blood, cord lining, and cord tissue.
- CEO
- Xiaoling Chen
- IPO
- 2013
- Employees
- 596
- HQ
- Singapore, CE, SG
Get TickerSpark's AI analysis on CLIFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $38.57M
- P/E
- -2.90
- PEG
- 0.09
- P/S
- 0.84
- P/B
- 0.31
- EV/EBITDA
- -2.92
- Div Yield
- 0.00%
- Gross Margin
- 56.65%
- Op Margin
- -33.96%
- Net Margin
- -28.93%
- ROE
- -10.28%
- ROIC
- -7.26%
Latest fiscal year · YoY change
- Revenue
- $38.82M+39.4%
- Gross Profit
- $21.73M+85.3%
- Op Income
- $-15,094,727
- Net Income
- $-12,630,568+32.4%
- EPS
- $-0.05+32.5%
- OCF Growth
- +104.5%
- FCF Growth
- +95.3%
- 52W High
- $0.15
- 52W Low
- $0.07
- 50D MA
- $0.15
- 200D MA
- $0.11
- Beta
- 0.67
- RSI (14)
- 100
- Avg Volume
- 1.39K
No earnings-call transcripts are available for CLIFF yet.
- Free Float
- 95.4%
- Shares Outstanding
- 256.31M
- Float Shares
- 244.44M
Our CLIFF coverage
Recent articles, reports, and earnings notes.
No research on CLIFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLIFF report →